Literature DB >> 8950991

Identification of a new family of Pbx-related homeobox genes.

T Nakamura1, N A Jenkins, N G Copeland.   

Abstract

The expression of Meis1 (a novel Pbx-related homeobox gene) and either Hoxa7 or Hoxa9 are coactivated by retroviral integration in BXH2 murine myeloid leukemias (T Nakamura, DA Largaespada, JD Shaughnessy Jr, NA Jenkins and NG Copeland (1996) Nature Genet. 12: 149-153). As Pbx proteins are Hox cofactors, which cooperatively bind DNA with Hox proteins to modulate the otherwise similar DNA bind specificities of Hox proteins, these results suggested that Meis1 may function as a cofactor for Hoxa7 and Hoxa9 in the induction of murine myeloid leukemias. By DNA cross-hybridization we have identified two Meis1-related genes, Meis2 and Meis3. Sequence analysis revealed extensive amino acid similarity among the three Meis proteins both within and outside of the homeodomain. Phylogenetic analysis showed that the Meis genes belong to a distinct family of Pbx-related genes. Chromosome mapping studies indicated that Meis2 and Meis3 are unlinked to Meis1 and map to mouse chromosome 2 and 7, respectively. The Meis genes displayed distinct but overlapping patterns of expression in normal tissues and were expressed in some cases of murine myeloid leukemia. The identification of two additional Meis genes identifies a new family of potential Hox cofactors as well as two new potential disease genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950991

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.

Authors:  W F Shen; S Rozenfeld; A Kwong; L G Köm ves; H J Lawrence; C Largman
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

Authors:  C P Chang; Y Jacobs; T Nakamura; N A Jenkins; N G Copeland; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.

Authors:  Ya-Xiong Chen; Jizhou Yan; Karen Keeshan; Anthony T Tubbs; Haoren Wang; Albert Silva; Eric J Brown; Jay L Hess; Warren S Pear; Xianxin Hua
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

4.  Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.

Authors:  Glen A Bjerke; Cathy Hyman-Walsh; David Wotton
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  Chromosomal mapping to 15q14 and expression analysis of the human MEIS2 homeobox gene.

Authors:  J E Smith; O Afonja; H T Yee; G Inghirami; K Takeshita
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

6.  AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins.

Authors:  W F Shen; J C Montgomery; S Rozenfeld; J J Moskow; H J Lawrence; A M Buchberg; C Largman
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals.

Authors:  T R Bürglin
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

8.  Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.

Authors:  Maria-Paz Garcia-Cuellar; Julia Steger; Elisa Füller; Katrin Hetzner; Robert K Slany
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

9.  An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).

Authors:  G H Swift; Y Liu; S D Rose; L J Bischof; S Steelman; A M Buchberg; C V Wright; R J MacDonald
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy.

Authors:  Glenda J Dickson; Fabio G Liberante; Laura M Kettyle; Kathleen A O'Hagan; Damian P J Finnegan; Lars Bullinger; Dirk Geerts; Mary Frances McMullin; Terry R J Lappin; Ken I Mills; Alexander Thompson
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.